242589 ⎘
2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#2Non-hormonal steroid modulators of NF-kB for treatment of disease
#3METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISEASES
#4Quinuclidine derivatives and medicinal compositions containing the same
#5Targeting the Steroidogenic Pathway For Treating and/or Preventing Allergic Diseases
#6Non-hormonal steroid modulators of NF-kB for treatment of disease
#7METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISEASES
#8Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
#9HUMAN ANTIBODY MOLECULES FOR IL-13
#10Non-hormonal steroid modulators of NF-kB for treatment of disease
#112,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#12Quinuclidine derivatives and medicinal compositions containing the same
#13Targeting the steroidogenic pathway for treating and/or preventing allergic diseases
#14Non-hormonal steroid modulators of NF-κB for treatment of disease
#15Respirable agglomerates of porous carrier particles and micronized drug
#16Quinuclidine derivatives and medicinal compositions containing the same
#17Human antibody molecules for IL-13
#18Anti-TNF antibodies, compositions, methods and uses
#19Use of pemirolast in the treatment of acute asthma
#202,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#21Quinuclidine derivatives and medicinal compositions containing the same
#22Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
#23Product and process for liquefaction of mucus or sputum
#24Quinuclidine derivatives and medicinal compositions containing the same
#25Respirable agglomerates of porous carrier particles and micronized drug
#26Targeting the steroidogenic pathway for treating and/or preventing allergic diseases
#27Anti-TNF antibodies, compositions, methods and uses
#282,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#29Quinuclidine derivatives and medicinal compositions containing the same
#30Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
#31Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases
#32Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
#33Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases
#34Anti-TNF antibodies, compositions, methods and uses
#35Indene derivatives as pharmaceutical agents
#36DRY POWDER AEROSOLS OF NANOPARTICULATE DRUGS
#37Method of using β-hydroxy-β-methylbutyrate to treat a condition
#38METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE TO REDUCE THE RISK OF INFECTION IN AN ELDERLY INDIVIDUAL
#39METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE FOR THE TREATMENT OF CANCER
#40USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE
#41Methods of using diaminopyrimidine as P2Xand P2X⅔ receptor modulators for treatment of respiratory and gastrointestinal diseases
#42Quinuclidine derivatives and medicinal compositions containing the same
#43Non-hormonal steroid modulators of NF-κB for treatment of disease
#44-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#45N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#46Methods of treatment using human antibody molecules for IL-13
#47Method for treating a mammal by administration of a compound having the ability to release CO
#48Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders
#49INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS
#50Quinuclidine derivatives and medicinal compositions containing the same
#51N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
#52USE OF CYCLODEXTRIN FOR TREATMENT AND PREVENTION OF BRONCHIAL INFLAMMATORY DISEASES
#53Indene derivatives as pharmaceutical agents
#54Compositions and methods for therapy for diseases characterized by defective chloride transport
#55METHOD OF TREATING AIRWAY DISEASES WITH BETA-ADRENERGIC INVERSE AGONISTS
#56Quinuclidine derivatives and medicinal compositions containing the same
#57COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#58Indene derivatives as pharmaceutical agents
#59Non-hormonal steroid modulators of NF-κB for treatment of disease
#60USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE
#61PRODUCT AND PROCESS FOR LIQUEFACTION OF MUCUS OR SPUTUM
#62Anti-TNF antibodies, compositions, methods and uses
#63Interleukin-4 receptors
#64-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
#65Method of inhibiting the emigration of cells from the intravascular compartment into tissues
#66Propellant-based nanoparticulate dry powder aerosols and method of making
#67Method of targeting sustained release formulations of therapeutic agents to treat lung diseases
#68Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms
#69Composition comprising an extract of and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
#70Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory disease
#71Human antibody molecules for IL-13
#72Anti-TNF antibodies, compositions, methods and uses
#73Anti-TNF antibodies, compositions, methods and uses
#74Method of treating neutrophil-related diseases with topical anesthetics
#75SOLID INHALATION FORMULATIONS OF DEHYDROEPIANDROSTERONE DERIVATIVES
#76LIQUID INHALATION FORMULATIONS OF DEHYDROEPIANDROSTERONE DERIVATIVES
#77Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases
#78COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#79Inhalation particles incorporating a combination of two or more active ingredients
#80Quinuclidine derivatives and medicinal compositions containing the same
#81Fatty Acid Modified Forms of Glucocorticoids
#82Treatment of respiratory diseases
#83Compounds and Methods for the Inhibition of the Expression of VCAM-1
#84Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
#85Therapeutically active triazoles and their use
#86Interleukin-9 mutein peptides
#87Product and process for liquefaction of mucus or sputum
#88Method of Treating Cancer Using Dithiocarbamate Derivatives
#89Aerosol composition comprising formoterol
#90Method of using beta-hydroxy-beta-methylbutyrate to treat allergies and asthma
#91Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
#92Human antibody molecules for IL-13
#93System and method for medical treatment
#94Quinuclidine derivatives and medicinal compositions containing the same
#95Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
#96Method for the production of propellant gas-free aerosols from aqueous medicament preparations
#97Compositions and methods for suppressing fibrocytes
#98Fatty acid modified forms of glucocorticoids
#99Methods of using diaminopyrimidine P2Xand P2Xreceptor modulators for treatment of respiratory and gastrointestinal diseases
#100Treating pulmonary disorders with gaseous agent causing repletion of GSNO
#101Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
#102Method for treating a mammal by administration of a compound having the ability to release CO
#103Aerosol formulation for inhalation comprising an anticholinergic
#1046,7-Oxygenated steroids and uses related thereto
#105Treatment of mucosal membranes
#106Method of treating airway diseases with beta-adrenergic inverse agonists
#107Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding
#108Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
#109Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
#110Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms
#111Quinuclidine derivatives and medicinal compositions containing the same
#112Quinuclidine derivatives and medicinal compositions containing the same
#113Method of treating neutrophil-related diseases with topical anesthetics
#114Therapeutic treatments using the direct application of antimicrobial metal compositions
#115Combination of formoterol and a tiotropium salt
#116Anti-angiogenic compositions and methods of use
#117Anti-angiogenic compositions and methods of use
#118Anti-angiogenic compositions and methods of use
#119Anti-angiogenic compositions and methods of use
#120Anti-angiogenic compositions and methods of use
#121Pharmaceutical combination
#122Local nasal immunotherapy with allergen strip for allergic rhinitis
#123Use of mometasone furoate for treating airway passage and lung disease
#124Treatment of inflammatory skin conditions
#125Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
#126Mucolytic and anti-elastase compounds and methods of use thereof
#127Aerosol composition
#128Methods for treating illnesses of the tracheo-bronchial tract, especially chronic obstructive pulmonary disease (COPD)
#129Quinuclidine derivatives and medicinal compositions containing the same
#130Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
#131Aerosol formulations containing P134a and particulate medicament
#132High storage stability inhalable compositions
#133Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
#134Method for administering selenium for treating patients suffering from systemic inflammatory response syndrome (SIRS), and composition for implementing the treatment
#135Inhalable formulation of a solution containing a tiotropium salt
#136Method of inhibiting the emigration of cells from the intravascular compartment into tissues
#137Aerosol composition comprising formoterol
#138Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
#139Antibodies to Interleukin-4 receptors and uses thereof
#140Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
#141Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
#142Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
#143Compounds and methods for the inhibition of the expression of VCAM-1
#144Anti-asthmatic combinations comprising surface active phospholipids
#145Human antibody molecules for IL-13
#146Medicaments for asthma treatment
#147Method for treating atopic disorders
#148Anti-angiogenic compositions and methods of use
#149Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
#150Treatment of respiratory diseases
#151Indene derivatives as pharmaceutical agents
#152Use of pemirolast